U.S. Renal Care: Akebia, U.S. Renal Care Enter Supply Contract; USRC Physicians To Prescribe Vafseo

Akebia Therapeutics (AKBA) and U.S. Renal Care announced entry into a multi-year commercial supply contract encompassing all USRC dialysis centers. The contract enables USRC attending physicians to prescribe Vafseo for patients on dialysis when it is expected to be available in January 2025.